Asahi Kasei Corp 13D and 13G filings for Calliditas Therapeutics AB (publ):
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-23 07:32 am Unchanged | 2024-09-23 | 13D | CALLIDITAS THERAPEUTICS AB SPO CALT | Asahi Kasei Corp | 53,156,176 98.380% | 0 (Unchanged) | Filing |
| 2024-09-17 07:55 am Purchase | 2024-09-13 | 13D | CALLIDITAS THERAPEUTICS AB SPO CALT | Asahi Kasei Corp | 53,156,176 98.380% | 2,743,279 (+5.44%) | Filing |
| 2024-09-09 8:57 pm Unchanged | 2024-09-09 | 13D | CALLIDITAS THERAPEUTICS AB SPO CALT | Asahi Kasei Corp | 50,412,897 93.300% | 0 (Unchanged) | Filing |
| 2024-09-03 9:55 pm Purchase | 2024-09-02 | 13D | CALLIDITAS THERAPEUTICS AB SPO CALT | Asahi Kasei Corp | 50,412,897 93.300% | 21,081,686 (+71.87%) | Filing |
| 2024-06-04 4:56 pm Purchase | 2024-05-27 | 13D | CALLIDITAS THERAPEUTICS AB SPO CALT | Asahi Kasei Corp | 29,331,211 54.600% | 29,331,211 (New Position) | Filing |